Cargando…
Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study
The systemic bioavailability of free fatty acid (FFA) forms of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) compared with ethyl ester (EE) forms is dependent on the presence of intestinal lipases and is highest during consumption of high-fat meals. Given that patients with cardiovascul...
Autores principales: | Offman, Elliot, Marenco, Ted, Ferber, Sandy, Johnson, Judith, Kling, Douglas, Curcio, Danielle, Davidson, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794864/ https://www.ncbi.nlm.nih.gov/pubmed/24124374 http://dx.doi.org/10.2147/VHRM.S50464 |
Ejemplares similares
-
Understanding hypertriglyceridemia in women: clinical impact and management with prescription omega-3-acid ethyl esters
por: Dayspring, Thomas D
Publicado: (2011) -
CMPF, a Metabolite Formed Upon Prescription Omega-3-Acid Ethyl Ester Supplementation, Prevents and Reverses Steatosis
por: Prentice, Kacey J., et al.
Publicado: (2017) -
Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products
por: Fialkow, Jonathan
Publicado: (2016) -
Bioavailability Study of an Innovative Orobuccal Formulation of Glutathione
por: Buonocore, Daniela, et al.
Publicado: (2016) -
Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update
por: Lin, Yiping, et al.
Publicado: (2021)